UT Health San Antonio Adds Ketamine to Amputee Care

Ketamine Enters a Texas Amputee Care Program

Texas Public Radio (TPR) reported on July 21, 2026, that UT Health San Antonio's Limb Optimization Program is incorporating ketamine therapy as part of an advanced, multidisciplinary approach to treating patients with limb loss. According to the outlet's description, the program pairs ketamine with other specialties in a coordinated model of amputee care, though the report as summarized does not detail specific dosing protocols, patient outcomes, or the exact clinical indications being targeted. Read the original report at Texas Public Radio.

For readers unfamiliar with limb optimization programs, these are typically hospital-based initiatives that bring together surgeons, physiatrists, physical and occupational therapists, prosthetists, and pain specialists to manage a patient's care from surgical planning through prosthetic fitting and long-term rehabilitation. Adding ketamine to that mix signals that pain management, not just mobility or wound healing, is being treated as a first-order concern in limb loss recovery.

Why Ketamine Shows Up in Amputee Care

The likely clinical rationale, based on how ketamine is generally used in pain medicine, centers on two overlapping problems amputees frequently face: acute post-surgical pain and phantom limb pain, a chronic condition in which patients perceive pain in a limb that is no longer present. Ketamine is an NMDA-receptor antagonist, a mechanism distinct from opioids, and researchers have studied sub-anesthetic ('low-dose') ketamine infusions for both perioperative pain control and chronic neuropathic pain syndromes, including phantom limb pain, for over two decades.

The evidence base for ketamine in phantom limb pain specifically is smaller and more mixed than for depression or some other chronic pain indications. Some clinical studies and case series have reported meaningful short-term reductions in phantom limb pain intensity with IV ketamine infusions, while others have found effects that fade quickly after the infusion ends or that vary widely between patients. This is consistent with the broader pattern seen across chronic pain applications of ketamine: it can produce real analgesic benefit for some patients, but individual response is unpredictable, and durability without a maintenance plan is often limited.

What makes a hospital-based, multidisciplinary setting notable is that it addresses one of the standing critiques of ketamine for chronic pain: that it works best as one component of a broader plan rather than a standalone treatment. Pairing infusions with physical therapy, prosthetic training, and psychological support gives patients a structure to consolidate any pain relief into functional gains, such as tolerating rehabilitation exercises or prosthetic fitting sessions that pain would otherwise make difficult.

What This Means for Patients and Caregivers Researching Ketamine

For readers of Low Dose Ketamine who are researching this therapy for themselves or a family member, a report like this one is useful mainly as a signal of where the field is heading, not as a source of protocol details. A few practical points are worth keeping in mind:

Ask what 'low-dose' means in context. Sub-anesthetic ketamine protocols vary considerably across institutions, from single infusions to short series delivered over days, and dosing for phantom limb pain is not standardized the way it is for some psychiatric indications. If you or a family member is considering this route after limb loss, ask the treating team directly what protocol they use, how many sessions are planned, and how response is measured.

Expect monitoring, not a one-time fix. Multidisciplinary programs typically build in vital sign monitoring during infusions and structured follow-up to track pain scores and function over time. That kind of monitoring, and a clear plan for what happens if benefit fades, is a reasonable thing to expect from any program offering ketamine for chronic or phantom limb pain, whether or not it's part of a larger limb care program.

Understand this is adjunctive, not a replacement for rehabilitation. Ketamine's role in this kind of program appears to be supportive of the broader recovery process, easing pain enough for patients to participate more fully in physical therapy and prosthetic training, rather than a substitute for that rehabilitation work.

Watch for published outcomes. TPR's report describes the program's existence and approach; it does not, per the available summary, include outcome data such as pain score reductions, infusion counts, or patient satisfaction figures. Readers who want to evaluate the strength of this approach should look for peer-reviewed outcome data or program-level reporting from UT Health San Antonio as it becomes available, rather than assuming effectiveness from the program's existence alone.

The broader trend here fits a pattern we've tracked at Low Dose Ketamine: ketamine is increasingly being integrated into structured, team-based clinical settings for pain indications beyond depression and PTSD, with hospitals treating it as one tool among several rather than a stand-alone intervention. That structural integration, embedding ketamine into a program with monitoring and follow-through, is generally a better sign for safety and consistency than ketamine offered in isolation. Patients considering this option should still bring the same questions they would ask about any pain therapy: what's the evidence for my specific condition, how will response be measured, and what's the plan if it doesn't work as hoped.